China Universal Asset Management Co., Ltd. Denali Therapeutics Inc. Transaction History
China Universal Asset Management Co., Ltd.
- $1.05 Billion
- Q1 2025
A detailed history of China Universal Asset Management Co., Ltd. transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, China Universal Asset Management Co., Ltd. holds 29,128 shares of DNLI stock, worth $397,014. This represents 0.04% of its overall portfolio holdings.
Number of Shares
29,128
Previous 30,517
4.55%
Holding current value
$397,014
Previous $621,000
36.23%
% of portfolio
0.04%
Previous 0.06%
Shares
16 transactions
Others Institutions Holding DNLI
# of Institutions
235Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$180 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$165 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$161 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$156 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$92.2 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.83B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...